{"id":350181,"date":"2025-11-18T08:51:32","date_gmt":"2025-11-18T03:21:32","guid":{"rendered":"https:\/\/forumias.com\/blog\/?page_id=350181"},"modified":"2025-11-18T08:51:32","modified_gmt":"2025-11-18T03:21:32","slug":"answered-examine-the-reasons-for-india-missing-the-2025-tb-elimination-target-despite-high-case-diagnosis-critically-analyze-the-systemic-gaps-contributing-to-the-global-burden","status":"publish","type":"page","link":"https:\/\/forumias.com\/blog\/answered-examine-the-reasons-for-india-missing-the-2025-tb-elimination-target-despite-high-case-diagnosis-critically-analyze-the-systemic-gaps-contributing-to-the-global-burden\/","title":{"rendered":"[Answered] Examine the reasons for India missing the 2025 TB elimination target despite high case diagnosis. Critically analyze the systemic gaps contributing to the global burden."},"content":{"rendered":"

Introduction<\/strong><\/h2>\n

Despite diagnosing over 26 lakh TB cases in 2024 and achieving 92% treatment coverage, India remains far from the 2025 elimination target, reflecting persistent structural, biomedical, and socio-economic barriers highlighted by the Global TB Report 2025.<\/p>\n

TB Burden of India<\/strong><\/h2>\n
    \n
  1. India accounts for the world\u2019s largest tuberculosis (TB) burden\u201427.1 lakh cases and over 3 lakh deaths in 2024.<\/strong><\/li>\n
  2. Despite progress in case detection and treatment coverage, the country has missed its ambitious goal of eliminating TB by 2025.<\/li>\n
  3. A combination of systemic weaknesses, social determinants, and programmatic disruptions continue to impede India\u2019s march toward \u201cEnd TB\u201d.<\/li>\n<\/ol>\n

    Reasons For India Missing The 2025 Tb Elimination Target<\/strong><\/h2>\n

    High diagnosis but slow decline in incidence and mortality<\/strong><\/p>\n

      \n
    1. The Global TB Report 2025 shows India achieved a 21% reduction in TB incidence<\/strong> and 28% reduction in deaths<\/strong> since 2015\u2014far below the 2025 milestones of 50% incidence reduction<\/strong> and 75% mortality reduction<\/strong>.<\/li>\n
    2. Elimination, defined as <1 case per million, remains distant. Although India diagnosed more than 80% of estimated cases<\/strong>, its large absolute burden means even small undiagnosed percentages translate into huge numbers\u2014contributing 8.8% of the global gap<\/strong> in undetected TB.<\/li>\n<\/ol>\n

      COVID-19 disruptions and programmatic diversion<\/strong><\/h2>\n
        \n
      1. The COVID-19 pandemic severely disrupted TB services<\/strong>, causing diagnostic delays, treatment interruptions, and resource diversion.<\/li>\n
      2. Studies by the Indian Council of Medical Research (ICMR) show that TB notifications fell by 25% during 2020, and the backlog took years to recover\u2014resulting in increased community transmission and drug resistance.<\/li>\n<\/ol>\n

        Persistent drug-resistant TB burden<\/strong><\/h2>\n
          \n
        1. India accounts for one-third of global drug-resistant TB (DR-TB)<\/strong> cases. 3.64% of new cases<\/strong> and 12.63% of previously treated cases<\/strong> were drug-resistant in 2024.<\/li>\n
        2. Transmission of untreated DR-TB poses epidemiological challenges, raising treatment costs and prolonging infectiousness. Despite the rollout of all-oral regimens (BPaL)<\/strong>, access gaps remain, especially for children.<\/li>\n<\/ol>\n

          Gaps in treatment adherence and preventive therapy<\/strong><\/h2>\n
            \n
          1. Treatment completion remains a challenge due to socioeconomic vulnerabilities, migration, stigma, and long treatment courses.<\/li>\n
          2. Non-adherence increases relapse and DR-TB.<\/li>\n
          3. Preventive therapy for high-risk contacts\u2014central to WHO\u2019s strategy\u2014remains underutilized due to supply shortages of isoniazid and rifapentine, and weak follow-up mechanisms.<\/li>\n<\/ol>\n

            Social determinants: malnutrition, pollution, diabetes<\/strong><\/h2>\n

            TB is a \u201cdisease of poverty.\u201d<\/strong><\/p>\n

              \n
            1. Malnutrition accounts for 34\u201340%<\/strong> of India\u2019s TB cases (Lancet Public Health, 2022).<\/li>\n
            2. Air pollution<\/strong>, especially in urban areas like Delhi, worsens TB outcomes.<\/li>\n
            3. Diabetes contributes 3.2 lakh cases<\/strong> in 2024, creating a syndemic relationship between chronic and infectious diseases.
              \nThese structural determinants amplify transmission and reduce treatment success.<\/li>\n<\/ol>\n

              Uneven availability of diagnostics and drugs<\/strong><\/h2>\n
                \n
              1. Despite innovations like AI-enabled handheld X-ray devices<\/strong> and expanded GeneXpert coverage, gaps persist: intermittent shortages of first-line drugs (as reported in 2024), weak diagnostic access in tribal and remote regions, insufficient paediatric formulations.<\/li>\n
              2. This limits the reach of the Ni-kshay ecosystem, though it remains a strong platform for digital treatment monitoring.<\/li>\n<\/ol>\n

                Private sector engagement and regulatory challenges<\/strong><\/h2>\n
                  \n
                1. Nearly 50% of TB patients<\/strong> first seek care in the private sector, where notification, standardised treatment, and follow-up remain inconsistent.<\/li>\n
                2. Although the Private Provider Interface Agency (PPIA) model in Mumbai and Patna showed success, national-scale integration remains incomplete.<\/li>\n<\/ol>\n

                  Conclusion<\/strong><\/h2>\n

                  Disease control fails without addressing structural inequities. India\u2019s TB elimination requires biomedical innovation combined with stronger health systems, social protection, and sustained multisectoral action.<\/p>\n","protected":false},"excerpt":{"rendered":"

                  Introduction Despite diagnosing over 26 lakh TB cases in 2024 and achieving 92% treatment coverage, India remains far from the 2025 elimination target, reflecting persistent structural, biomedical, and socio-economic barriers highlighted by the Global TB Report 2025. TB Burden of India India accounts for the world\u2019s largest tuberculosis (TB) burden\u201427.1 lakh cases and over 3… Continue reading [Answered] Examine the reasons for India missing the 2025 TB elimination target despite high case diagnosis. Critically analyze the systemic gaps contributing to the global burden.<\/span><\/a><\/p>\n","protected":false},"author":10320,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"jetpack_post_was_ever_published":false,"footnotes":""},"class_list":["post-350181","page","type-page","status-publish","hentry","entry"],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/pages\/350181","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/users\/10320"}],"replies":[{"embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/comments?post=350181"}],"version-history":[{"count":0,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/pages\/350181\/revisions"}],"wp:attachment":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/media?parent=350181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}